Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Bouayad, Asmàa ^a   Kajino, Hiroki ^b,d   Waleh, Nahid ^b   Fouron, Jean Claude ^a   Andelfinger, Gregor ^a   Varma, Daya R ^c   Skoll, Amanda ^a   Vazquez, Alejandro ^a   Gobeil Jr , Fernand ^a   Clyman, Ronald I ^b   Chemtob, Sylvain ^a,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

ATP sensitive potassium channels; Ductus arteriosus; EP receptors

Indexed keywords

11 DEOXY 16 PHENOXY 17,18,19,20 TETRANORPROSTAGLANDIN E1; 16,16 DIMETHYLPROSTAGLANDIN E2; 4 AMINOPYRIDINE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; 8 BROMO CYCLIC AMP; ADENOSINE TRIPHOSPHATE; BUTAPROST; CARBACYCLIN; CICAPROST; CYCLIC AMP; FORSKOLIN; GLIBENCLAMIDE; GR 63799X; IBERIOTOXIN; INDOMETACIN; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; RNA; UNCLASSIFIED DRUG; 11-DEOXY-16-PHENOXY-17,18,19,20-TETRANORPROSTAGLANDIN E1; 16,16 DIMETHYLPROSTAGLANDIN F2ALPHA; 16,16-DIMETHYLPROSTAGLANDIN F2ALPHA; 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIULCER AGENT; BIPHENYL DERIVATIVE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; TRITIUM; XANTHENE DERIVATIVE; XANTHONE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; LIGAND BINDING; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATENT DUCTUS ARTERIOSUS; POLYMERASE CHAIN REACTION; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; ANIMAL; BINDING COMPETITION; CHEMISTRY; DRUG EFFECT; DUCTUS ARTERIOSUS; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; RADIOASSAY; SHEEP; VASOCONSTRICTION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPROSTADIL; ANIMALS; ANIMALS, NEWBORN; ANTI-ARRHYTHMIA AGENTS; ANTI-ULCER AGENTS; BINDING, COMPETITIVE; BIPHENYL COMPOUNDS; DINOPROST; DUCTUS ARTERIOSUS; FEMALE; FETUS; FORSKOLIN; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS; PREGNANCY; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS E, SYNTHETIC; RADIOLIGAND ASSAY; RECEPTORS, PROSTAGLANDIN E; SHEEP; TRITIUM; VASOCONSTRICTION; XANTHENES; XANTHONES;

EID: 0035344138     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.5.h2342     Document Type: Article

References (45)

1. Abramovitz M, Adam MA, Boie Y, Carrière MC, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, and Metters KM. The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochem Biophys Acta 1483: 285-293, 2000.
2. 2, and nitric oxide donor, 3-morpholinosyadenosine, in lambs and their clinical implications. Brit Heart J 73: 177-181, 1995.
3. Armstead WM. Role of nitric oxide and cAMP in prostaglandin-induced pial arterial vasodilation. Am J Physiol Heart Circ Physiol 268: H1436-H1440, 1995.
4. 2 subtype. JBiol Chem 269: 11873-11877, 1994.
5. 2 receptor subtypes in porcine ductus arteriosus. Circulation 100: 1751-1756, 1999.
6. Bonnin P, Fouron JC, Teyssier G, Sonesson SE, and Skoll A. Quantitative assessment of circulatory changes in the fetal aortic isthmus during progressive increase of resistance to umbilical blood flow. Circulation 88: 216-222, 1993.
7. 2 may activate ATP sensitive channels in the isolated rat heart. Cardiovasc Res 28: 901-905, 1994.
8. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, and White RE. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol Heart Circ Physiol 273: H76-H84, 1997.
9. Chen J, Champa-Rodriguez ML, and Woodward DF. Identification of a prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br J Pharmacol 116: 3035-3041, 1995.
10. Clyman RI, Hardy P, Waleh N, Chen YQ, Mauray F, Fouron JC, and Chemtob S. Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus. Am J Physiol Regulatory Integrative Comp Physiol 276: R913-R921, 1999.
11. Clyman RI, Mauray F, Roman C, Heymann MA, and Payne B. Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E2. Circulation 18: 433-436, 1983.
12. 1α. Prostaglandins 16: 259-264, 1978.
13. Clyman RI, Waleh N, Black SM, Riemer RK, Mauray F, and Chen YK. Regulation of ductus arteriosus patency by nitric oxide in fetal lambs. Pediatr Res 43: 633-644, 1998.
14. 2 on the lamb ductus arteriosus. Prostaglandins 15: 551-556, 1978.
15. Coceani F and Olley PM. The control of cardiovascular shunts in the fetal and the perinatal period. Can J Physiol Pharmacol 66: 1129-1134, 1987.
16. Coleman RA, Smith WL, and Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution and structure of receptors and their subtypes. Pharmacol Rev 46: 205-229, 1994.
17. 2+ than aorta or main pulmonary artery. Cardiovasc Res 33: 223-229, 1997.
18. DeBlasi A, O'Reilly K, and Motulsky HJ. Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10: 227-229, 1989.
19. Hampl V, Huang JM, Weir EK, and Archer SL. Activation of the cGMP-dependent protein kinase mimics the stimulatory effect of nitric oxide and cGMP on calcium-gated potassium channels. Physiol Res 44: 39-44, 1995.
20. Heymann MA and Rudolph AM. Control of the ductus arteriosus. Physiol Rev 55: 62-78, 1975.
21. 2 subtype. J Biol Chem 268: 7759-7762, 1993.
22. + channel blockers on beta-adrenoceptor-mediated vasorelaxation of rat mesenteric artery. J Cardiovasc Pharmacol 29: 515-519, 1997.
23. Kageyama M, Yanagisawa T, and Taira N. Calcitonin generelated peptide relaxes porcine coronary arteries via cyclic AMP-dependent mechanisms, but not activation of ATP-sensitive potassium channels. J Pharmacol Exp Ther 265: 490-497, 1993.
24. 3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 48: 869-879, 1995.
25. 2α receptors in brain synaptosomes of newborn than of adult pigs. J Pharmacol Exp Ther 267: 1292-1297, 1993.
26. 5 and gamma-aminobutyric acid A receptors. Nature 403: 274-280, 2000.
27. 1 receptor: an inducible G protein coupled receptor. Can J Physiol Pharmacol 75: 725-730, 1997.
28. Matthews JC. Fundamentals of Receptor, Enzyme and Transport Kinetics. Boca Raton, FL: CRC, 1993, p 3-40.
29. 4 subtype: differential regulation in monocytoid and lymphoid lineage cells by phorbol ester. J Mol Med 74: 333-336, 1996.
30. Nakanishi T, Gu H, Hagiwara N, and Momma K. Mechanisms of oxygen-induced contraction of ductus arteriosus isolated from the fetal rabbit. Circ Res 72: 1218-1228, 1993.
31. 3 determines G-protein specificity. Nature 365: 166-170, 1993.
32. Narumiya S, Sugimoto Y, and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 193-226, 1999.
33. 4 triggers remodeling of cardiovascular system at birth. Nature 390: 78-81, 1997.
34. Olszewski NE, Gast RT, and Ausubel FM. A dual-labeling method for identifying differentially expressed genes: use in the identification of cDNA clones that hybridize to RNAs whose abundance in tomato flowers is potentially regulated by giberellins. Gene 77: 155-162, 1989.
35. 2 subtype. Cell Mol Biol Res 200: 1329-1333, 1994.
36. Satake N, Shibata M, and Shibata S. The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings. Br J Pharmacol 119: 505-510, 1996.
37. Shaddy RE, Mak C, and Bristow MR. Comparative in vitro myocardial inotropic effects and in vivo hemodynamic effects of forskolin and isoproterenol in young lambs. Pediatr Res 25: 580-584, 1989.
38. Simonson MS and Dunn MJ. Cellular signaling by peptides of the endothelin gene family. FASEB J 4: 2989-3000, 1990.
39. Smith GC, Coleman RA, and McGrath JC. Characterization of dilator prostanoid receptors in fetal rabbit ductus arteriosus. J Pharmacol Exp Ther 271: 390-396, 1994.
40. Tristani-Firouzi M, Reeve HL, Tolarova S, Weir EK, and Archer SL. Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J Clin Invest 98: 1959-1965, 1996.
41. 1, isoproterenol and forskolin on cyclic AMP levels and tension in rabbit aortic rings. Life Sci 39: 303-311, 1986.
42. + channels in smooth muscle cells of guinea-pig mesenteric lymphatics: role in nitric oxide and beta-adrenoceptor agonist-induced hyperpolarizations. Br J Pharmacol 125: 17-22, 1998.
43. Walsh RS and Mentzer RM. Role of cyclic nucleotides in relaxation of fetal lamb ductus arteriosus. Surgery 102: 313-318, 1987.
44. + channel activation by calcitonin-gene related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507: 117-129, 1998.
45. Ziober BL, Chen YQ, Ramos DM, Waleh N, and Kramer RH. Expression of the alpha7betal laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ 10: 479-490, 1999.